Next week, we will be in the beautiful city of Lyon to participate to Forum Labo with our partners Molecular Devices and INTEGRA Biosciences.

In this event we will present our brand new BIOMIMESYS® technology for 3D cell culture on INTEGRA Biosciences’s booth (#B18). This is an unique and natural hydroscaffold based on hyaluronic acid, biofunctionalized with other extracellular matrix components (like collagens). Precast in 96-well plates, this matrix is designed to better mimic the cellular microenvironment of every organ! Moreover, BIOMIMESYS® matrix is compatible with automation ; the plates can be seeded and treated easily using the VIAFLO 96/384!

We will also present our laboratories in virtual reality on Molecular Devices’ booth (Booth #D32) and, if you are interested, we will be happy to exchange about pictures analyzing with MetaXpress software, use of machine learning and artificial intelligence in pictures segmentation and, of course, capabilities of augmented reality and virtual reality in cells visualization.

If you want to meet Nathalie (CEO), Elodie (Study Director) or me (Digital Coordinator / CDO) you can use the networking tool of the event (Lab Social’Club) or just contact us!

See you soon in Lyon!


Grégory MAUBON

Grégory MAUBON is Chief Data Officer and digital coordinator at HCS Pharma, a biotech startup focused in high content screening and complex diseases. He manages IT missions and leads digital usages linked to company needs. He is also a Augmented Reality Evangelist (presenter and lecturer) since 2008, where he created www.augmented-reality.fr and founded in 2010 RA'pro (the augmented reality promotion association). He helped many companies (in several domains) to define precisely their augmented reality needs and supported them in the implementation.

1 Comment

Spring is coming and it's time to change (our website!) | HCS Pharma · March 26, 2018 at 1:18 pm

[…] be more clear for you. Of course we are interested by your feedbacks! Why don’t you come to Forum Labo to talk about it (and about our […]

Leave a Reply